Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

USA Today Links the Immunocompromised to CLL Society’s COVID-19 Action Plan

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

In their 1/28/2023 article: Weak immune system? Government offers advice to help at-risk people avoid COVID-19 infections in the wake of the FDA’s withdrawal of Evusheld’s emergency authorization as it was ineffective for over 90% of the active SARS-CoV-2 variants of concerns, USA Today urges the immunocompromised to have a plan in place and links to CLL Society’s COVID-19 Action Plan as a helpful resource.

CLL Society is proud of the expanded role it is playing in helping not just the CLL / SLL community but all those who are vulnerable because they are immunocompromised or immune suppressed due to medications.